A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
AO GENERIUM
Huashan Hospital
Huabo Biopharm Co., Ltd.
Ewha Womans University Mokdong Hospital
Jiangsu Hansoh Pharmaceutical Co., Ltd.
The Affiliated Hospital of Qingdao University
Kineta Inc.
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Regina Elena Cancer Institute
Imperial College London
University Hospital, Clermont-Ferrand
Helsinki University Central Hospital
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Centre Hospitalier Universitaire de Besancon
Herlev and Gentofte Hospital
Innersight Labs Ltd
RenJi Hospital
I.M. Sechenov First Moscow State Medical University
I.M. Sechenov First Moscow State Medical University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Herlev and Gentofte Hospital
Shanghai Junshi Bioscience Co., Ltd.
Sun Yat-sen University
West China Hospital
University Hospital, Grenoble
Cedars-Sinai Medical Center
University Hospital, Grenoble
Instituto do Cancer do Estado de São Paulo
Centre Hospitalier Universitaire de Besancon
University of Sao Paulo
University of Zurich
University Hospital, Angers
European Organisation for Research and Treatment of Cancer - EORTC
Consorzio Oncotech
Ottawa Hospital Research Institute
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
RenJi Hospital
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)